Primary Site >> Pancreatic Cancer
Gene >> AXL
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Strong association of ARK5 with tumor invasion and metastasis. PMID: 15354411 |
Ref: The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. PMID: 19252414 |
Ref: Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. PMID: 20922806 |
Ref: Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. PMID: 22890323 Ref: Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy. PMID: 23872419 |
Ref: Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. PMID: 24240689 Ref: Imaging Axl expression in pancreatic and prostate cancer xenografts. PMID: 24333418 Ref: Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics. PMID: 24895378 Ref: A new goniothalamin N-acylated aza-derivative strongly downregulates mediators of signaling transduction associated with pancreatic cancer aggressiveness. PMID: 25305718 Ref: AXL kinase as a novel target for cancer therapy. PMID: 25337673 |
Ref: Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. PMID: 25736685 Ref: Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. PMID: 26206560 |
Ref: Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma. PMID: 27629742 |
Ref: Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. PMID: 29157747 Ref: Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. PMID: 29180468 Ref: Axl inhibitors as novel cancer therapeutic agents. PMID: 29496493 Ref: Does Axl have potential as a therapeutic target in pancreatic cancer? PMID: 30244621 |